메뉴 건너뛰기




Volumn 64, Issue 25, 2014, Pages 2805-2806

Different potencies of angiotensin receptor blockers at suppressing adrenal β-arrestin1-dependent post-myocardial infarction hyperaldosteronism

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; BETA ARRESTIN 1; BRAIN NATRIURETIC PEPTIDE; CANDESARTAN; COLLAGEN TYPE 1; IRBESARTAN; VALSARTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE; VALINE;

EID: 84919673612     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.09.070     Document Type: Letter
Times cited : (33)

References (5)
  • 1
    • 65249162262 scopus 로고    scopus 로고
    • An adrenal beta-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo
    • A. Lymperopoulos, G. Rengo, C. Zincarelli, J. Kim, S. Soltys, and W.J. Koch An adrenal beta-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo Proc Natl Acad Sci U S A 106 2009 5825 5830
    • (2009) Proc Natl Acad Sci U S A , vol.106 , pp. 5825-5830
    • Lymperopoulos, A.1    Rengo, G.2    Zincarelli, C.3    Kim, J.4    Soltys, S.5    Koch, W.J.6
  • 2
    • 78651326867 scopus 로고    scopus 로고
    • Adrenal beta-arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels
    • A. Lymperopoulos, G. Rengo, C. Zincarelli, J. Kim, and W.J. Koch Adrenal beta-arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels J Am Coll Cardiol 57 2011 356 365
    • (2011) J Am Coll Cardiol , vol.57 , pp. 356-365
    • Lymperopoulos, A.1    Rengo, G.2    Zincarelli, C.3    Kim, J.4    Koch, W.J.5
  • 3
    • 77549088386 scopus 로고    scopus 로고
    • The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: A systematic review and meta-analysis
    • R.V. Shah, A.S. Desai, and M.M. Givertz The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis J Card Fail 16 2010 260 267
    • (2010) J Card Fail , vol.16 , pp. 260-267
    • Shah, R.V.1    Desai, A.S.2    Givertz, M.M.3
  • 4
    • 57349142933 scopus 로고    scopus 로고
    • Irbesartan in patients with heart failure and preserved ejection fraction
    • I-PRESERVE Investigators
    • B.M. Massie, P.E. Carson, J.J. McMurray I-PRESERVE Investigators Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2008 2456 2467
    • (2008) N Engl J Med , vol.359 , pp. 2456-2467
    • Massie, B.M.1    Carson, P.E.2    McMurray, J.J.3
  • 5
    • 34548163060 scopus 로고    scopus 로고
    • The incidence and implications of aldosterone breakthrough
    • A.S. Bomback, and P.J. Klemmer The incidence and implications of aldosterone breakthrough Nat Clin Pract Nephrol 3 2007 486 492
    • (2007) Nat Clin Pract Nephrol , vol.3 , pp. 486-492
    • Bomback, A.S.1    Klemmer, P.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.